Targeting the tumour vasculature in mesothelioma

Lancet Oncol. 2018 Jun;19(6):723-724. doi: 10.1016/S1470-2045(18)30248-1. Epub 2018 May 9.

Author

Dean A Fennell¹

Affiliation

¹ Cancer Research UK Centre, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester LE1 9HN, UK. Electronic address: df132@le.ac.uk.

PMID: 29753701
DOI: 10.1016/S1470-2045(18)30248-1

No abstract available

Publication types

Comment

MeSH terms

Double-Blind Method
Humans
Lung Neoplasms*
Mesothelioma*
Recombinant Fusion Proteins
Tumor Necrosis Factor-alpha

Substances

Recombinant Fusion Proteins
Tumor Necrosis Factor-alpha
tumor necrosis factor-alpha, CNGRC fusion protein, human